The Care and Trial Site Registry (CTSR): A Powerful Tool for Clinical Research in Rare Diseases
The Neuromuscular Disease Network for Canada (NMD4C), Muscular Dystrophy Canada (MDC) and The Care and Trial Site Registry (CTSR) are pleased to invite you to a webinar on the CTSR, a worldwide database of sites that provide services for patients with neuromuscular and/or neurodegenerative conditions. The CTSR aims to accelerate clinical trial readiness, by collecting data needed to respond to feasibility and research inquiries from industry, academics, and patient organisations.
This webinar is primarily targeted at Canadian clinicians, academics, and trainees with an interest in conducting clinical trials in neuromuscular disease. NMD4C and MDC are providing organisational and technical support.
Speakers:
- Dr. Craig Campbell
- Sunil Rodger
- Bonnie Wooten
Learning Objectives:
- The benefits of the CTSR for sites and patients
- The partnership between the NMD4C and the CTSR
- How to register and update your site in the CTSR
- How the NMD4C Clinical Trial Concierge can support your involvement with the CTSR